telocinobufagin,
Telocinobufagin,
Telocinobufogenin,
Telecinobufagin,
472-26-4,
NSC 119989,
CHEBI:80908,
Telobufotoxin,
BRN 0056287,
5-[(3S,5S,8R,9S,10R,13R,14S,17R)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one,
5.beta.-Bufa-20, 3.beta.,5,14-trihydroxy-,
3-beta,5,14-Trihydroxy-5-beta-bufa-20,22-dienolide,
Bufa-20, 3,5,14-trihydroxy-, (3.beta.,5.beta.)-,
Telobufotoxin;,
3,5,14-Trihydroxybufa-20,22-dienolide,
AC1Q6ASG,
4-18-00-02553 (Beilstein Handbook Reference),
5-beta-BUFA-20,22-DIENOLIDE, 3-beta,5,14-TRIHYDROXY-,
SCHEMBL866975,
Telobufotoxin;Telocinobufogenin,
AC1L627G,
CHEMBL463273,
HY-N0885,
NSC90782,
ZINC4917352,
4094AH,
MFCD00468034,
NSC 90782,
NSC-90782,
NSC119989,
AKOS030526152,
CS-3703,
NSC-119989,
NCGC00485919-01,
C17072,
3|A,5,14-Trihydroxy- 5|A-bufa-20,22-dienolide,
3beta,5,14-Trihydroxy-5beta-bufa-20,22-dienolide,
(3|A,5|A)-3,5,14-Trihydroxybufa-20,22-dienolide,
5beta-Bufa-20,22-dienolide, 3beta,5,14-trihydroxy- (8CI),
Bufa-20,22-dienolide, 3,5,14-trihydroxy-, (3beta,5beta)- (9CI),
C24H34O5,
AR-1L5918,
CID259991,
ACN-047210,
C24-H34-O5,
480-54-6,